A fine-tuned comprehensive overview of antibody-driven ex-vivo assays for primary murine T cell activation

T cell activation is a fundamental process in adaptive immunity, requiring the precise orchestration of signaling through the T cell receptor/CD3 complex and costimulatory pathways. In vitro murine T cell activation assays are critical tools for investigating these signaling mechanisms. They bridge the gap between basic mechanistic understanding and clinical translation, with applications spanning cancer immunotherapy and infectious disease treatment. These assays provide controlled experimental platforms to dissect T cell biology, screen therapeutic compounds, and identify novel signaling pathways that govern immune responses. Despite decades of research and widespread use of T cell activation assays, significant methodological heterogeneity persists across laboratories, creating challenges for data interpretation and experimental reproducibility. To address this, we performed a side-by-side comparison of the common antibody-driven T cell activation assays, examining key variables such as antibody dosage, format and the presence or absence of accessory cells. By integrating multiple parameter readouts, we provide experimental-based evidence of how these various stimulation methods modulate several key parameters of early T cell activation. Based on this evidence, we discuss the factors to consider when choosing one approach over another and provide practical guidelines to establish and improve the workflow of such assays.